£100.08

Springer Current Strategies in Cancer Gene Therapy: 209 (Recent Results in Cancer Research, 209)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£100 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£105.69 £99.52 £100.87 £102.21 £103.56 £104.90 £106.25 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 3 price levels

Days at Price
Current Price
5 days · current 70 days 15 days 0 18 35 53 70 £100 £105 £106 Days at Price

Price Analysis

Most common price: £105 (70 days, 77.8%)

Price range: £100 - £106

Price levels: 3 different prices over 90 days

Description

This book describes important developments and emerging trends in experimental and clinical cancer gene therapy. It reflects the tremendous advances made over recent years with respect to immunogenes, suicide genes and gene correction therapies, as well as in gene suppression and miRNA therapies. Many of the described strategies focus on the generation of more efficient and specific means of attack at known and novel cellular targets associated with tumor development and progression. The book also details parallel improvements in vector design, vector delivery, and therapeutic efficacy. It offers readers a stimulating, broad overview of advances in the field, linking experimental strategies to their clinical applications.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Gene-Based Therapies for Cancer (Current Cancer Research)
90% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.50 18 May 2026
Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)
84% match

Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

Wiley

£105.71 04 May 2026
Gene Regulation and Therapeutics for Cancer
84% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£69.94 11 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
83% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.27 18 May 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
83% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.48 18 May 2026
MicroRNAs in Cancer Translational Research
82% match

MicroRNAs in Cancer Translational Research

Springer

£129.92 10 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
82% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 18 May 2026
Viruses, Genes, and Cancer: 407 (Current Topics in Microbiology and Immunology, 407)
81% match

Viruses, Genes, and Cancer: 407 (Current Topics in Microbiology and Immunology, 407)

Springer

£115.87 18 May 2026
Viruses, Genes, and Cancer: 407 (Current Topics in Microbiology and Immunology, 407)
81% match

Viruses, Genes, and Cancer: 407 (Current Topics in Microbiology and Immunology, 407)

Springer

£83.89 18 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
81% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
81% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 17 May 2026
Cancer Immunotherapy: Paradigms, Practice and Promise
81% match

Cancer Immunotherapy: Paradigms, Practice and Promise

Springer

£108.92 18 May 2026
Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)
80% match

Gene Therapy of Solid Cancers: Methods and Protocols: 1317 (Methods in Molecular Biology, 1317)

Humana

£73.56 18 May 2026
Genetic Instability and Tumorigenesis: 221 (Current Topics in Microbiology and Immunology, 221)
80% match

Genetic Instability and Tumorigenesis: 221 (Current Topics in Microbiology and Immunology, 221)

Springer

£72.98 11 May 2026
Male Reproductive Cancers: Epidemiology, Pathology and Genetics (Cancer Genetics)
80% match

Male Reproductive Cancers: Epidemiology, Pathology and Genetics (Cancer Genetics)

Springer

£141.83 18 May 2026
Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)
80% match

Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)

Springer

£73.10 15 May 2026
Gene Therapy of Autoimmune Disease (Medical Intelligence Unit)
80% match

Gene Therapy of Autoimmune Disease (Medical Intelligence Unit)

Springer

£106.16 18 May 2026
Molecular Pathogenesis of Colorectal Cancer
80% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£110.54 18 May 2026
Stem Cells and Cancer Stem Cells, Volume 13: Therapeutic Applications in Disease and Injury
80% match

Stem Cells and Cancer Stem Cells, Volume 13: Therapeutic Applications in Disease and Injury

Springer

£73.44 18 May 2026
Gynecologic Oncology: Controversies and New Developments: 70 (Cancer Treatment and Research, 70)
80% match

Gynecologic Oncology: Controversies and New Developments: 70 (Cancer Treatment and Research, 70)

Springer

£113.76 18 May 2026
Nutraceuticals and Cancer
80% match

Nutraceuticals and Cancer

Springer

£113.76 18 May 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
80% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 18 May 2026
Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications
80% match

Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications

Springer

£136.92 18 May 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
80% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 18 May 2026